Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Jan 15, 2020 0.0990€ 0.0990€ 0.0990€ 0.0990€ 10 000
Jan 13, 2020 0.101€ 0.102€ 0.101€ 0.102€ 10 000
Jan 10, 2020 0.0995€ 0.0995€ 0.0995€ 0.0995€ 1 000
Jan 09, 2020 0.0990€ 0.0990€ 0.0990€ 0.0990€ 1 000
Jan 08, 2020 0.0975€ 0.0975€ 0.0975€ 0.0975€ 1 000
Jan 07, 2020 0.0995€ 0.0995€ 0.0995€ 0.0995€ 1 000
Jan 06, 2020 0.100€ 0.100€ 0.100€ 0.100€ 1 000
Jan 03, 2020 0.100€ 0.100€ 0.100€ 0.100€ 1 000
Jan 02, 2020 0.0990€ 0.0990€ 0.0990€ 0.0990€ 1 000
Dec 30, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 27, 2019 0.102€ 0.102€ 0.102€ 0.102€ 1 000
Dec 23, 2019 0.102€ 0.102€ 0.102€ 0.102€ 1 000
Dec 20, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 19, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 18, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 17, 2019 0.102€ 0.102€ 0.102€ 0.102€ 1 000
Dec 16, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 13, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 12, 2019 0.0995€ 0.101€ 0.0995€ 0.101€ 1 000
Dec 11, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 10, 2019 0.100€ 0.100€ 0.100€ 0.100€ 1 000
Dec 09, 2019 0.100€ 0.100€ 0.100€ 0.100€ 1 000
Dec 06, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 05, 2019 0.101€ 0.101€ 0.101€ 0.101€ 1 000
Dec 04, 2019 0.100€ 0.100€ 0.100€ 0.100€ 1 000
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT